Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1730 (LINC01730)

Target
LINC01730
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 1730 (LINC01730) is a non-coding RNA gene classified as a long intergenic non-coding RNA (lincRNA), typically denoting an RNA transcript longer than 200 nucleotides that does not encode protein and is located in intergenic regions of the genome, meaning its sequence does not overlap coding genes[1][5]. LINC01730 is listed in gene databases such as NCBI Gene and Ensembl, but there is no published experimental literature as of 2025 detailing its biological function, tissue distribution, regulation, or association with human diseases. While some lincRNAs are increasingly recognized as regulatory molecules with roles in gene expression, cell signaling, and disease (especially cancer), no such evidence currently exists for LINC01730 specifically[1][5].

Other names
LINC01730long intergenic non-protein coding RNA 1730
02

Mechanism of action

None. As there are no drugs targeting LINC01730, mechanisms of action cannot be described.

03

Biological functions

Unknown. There is currently no experimentally validated biological function specifically attributed to LINC01730 in available databases or literature. LincRNAs in general may be involved in regulation of gene expression, chromatin modification, acting as molecular sponges for miRNAs, and formation of ribonucleoprotein complexes.
04

Disease associations

Unknown. No specific disease associations, biomarker roles, or links to cancer, inflammation, neurodegenerative diseases, or other pathologies have been described for LINC01730 as of the current search. This is in contrast with many other lincRNAs, which often have functional evidence in cancer or other diseases.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1730 (LINC01730).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1730 (LINC01730).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call